DRI Healthcare Trust (TSE:DHT.UN – Get Free Report) shot up 3.3% on Tuesday . The company traded as high as C$12.33 and last traded at C$12.15. 33,446 shares traded hands during trading, a decline of 20% from the average session volume of 42,016 shares. The stock had previously closed at C$11.76.
Analysts Set New Price Targets
A number of analysts have recently weighed in on DHT.UN shares. Scotiabank raised their price target on shares of DRI Healthcare Trust from C$21.00 to C$22.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. Raymond James decreased their target price on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a research report on Wednesday, November 13th. Finally, CIBC cut their price target on shares of DRI Healthcare Trust from C$19.50 to C$18.00 and set an “outperform” rating on the stock in a report on Thursday, December 12th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, DRI Healthcare Trust has an average rating of “Moderate Buy” and an average price target of C$17.94.
Check Out Our Latest Stock Analysis on DHT.UN
DRI Healthcare Trust Trading Up 3.3 %
About DRI Healthcare Trust
DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term.
Read More
- Five stocks we like better than DRI Healthcare Trust
- How to Use the MarketBeat Stock Screener
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Investing in Construction Stocks
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- The Basics of Support and Resistance
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.